Xtl Biopharmaceuticals annual gross margin
2024
Xtl Biopharmaceuticals Gross Margin Growth & History (XTLB)
Xtl Biopharmaceuticals's gross margin was 0.67% for fiscal 2024.
View full Xtl Biopharmaceuticals company overviewXtl Biopharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 0.67% | — |
Xtl Biopharmaceuticals gross margin trends
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xtl Biopharmaceuticals source filings ↗